---
title: "MiniMed 780G Performance in Asian Adults With Type 1 Diabetes: 24-Week Exploratory Study"
id: "pubmed-43056643"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43056643"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43056643/"
doi: "10.2196/94885"
published_at: "2026-11-19T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# MiniMed 780G Performance in Asian Adults With Type 1 Diabetes: 24-Week Exploratory Study
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43056643
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43056643/)
- **DOI:** [10.2196/94885](https://doi.org/10.2196%2F94885)
- **Published At:** 2026-11-19T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- A prospective, single-center pilot enrolled adults with **type 1 diabetes** switched from multiple daily injections or conventional pump therapy to the **MiniMed 780G** advanced hybrid closed-loop system for 24 weeks. - Nine participants completed the study (n=5 male); mean age was 35 years (SD 10.9). - Primary outcome measured: change in **HbA1c** at 12 and 24 weeks; investigators reported mean HbA1c fell from 7.3% (SD 0.9) at baseline to 6.9% (SD 0.6) at 12 weeks and 7.0% (SD 0.6) at 24 weeks. - All participants met predefined continuous glucose monitoring targets at both 12 and 24 weeks: time in range >70%, time above range <25%, and time below range <4%. - Total daily insulin dose decreased for every patient by 24 weeks, according to study data. - The study team described the system as usable and safe in this small Asian cohort, but the abstract did not provide granular adverse event data or detailed quality-of-life scores. - This was an exploratory pilot; the source did not report sample size calculations, randomization details, or long-term follow-up beyond 24 weeks. - Key unanswered items in the source: per-patient CGM metrics beyond target attainment, specific QoL outcomes, adverse event descriptions, and methodological specifics such as eligibility criteria and insulin settings.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43056643/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056643%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43056643/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43056643/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43056643/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43056643/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43056643/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056643%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056643%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43056643/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056643/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056643/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43056643/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056643/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43056643/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43056643/#abstract) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43056643/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43056643/#substances) Title & authors Abstract MeSH terms Substances JMIR Form Res Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22JMIR+Form+Res%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22JMIR+Form+Res%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) . 2026 Nov 19:10:e94885. doi: 10.2196/94885. # Advanced Hybrid Closed-Loop Insulin Delivery System in Asian Patients With Type 1 Diabetes: Exploratory Study [Wanling Zeng](https://pubmed.ncbi.nlm.nih.gov/?term=Zeng+W&cauthor_id=43056643)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056643/#full-view-affiliation-1 "Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore, 65 67888833."), [Authilakshmy N Manikam](https://pubmed.ncbi.nlm.nih.gov/?term=Manikam+AN&cauthor_id=43056643)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056643/#full-view-affiliation-1 "Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore, 65 67888833."), [Joan Khoo](https://pubmed.ncbi.nlm.nih.gov/?term=Khoo+J&cauthor_id=43056643)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056643/#full-view-affiliation-1 "Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore, 65 67888833.") Affiliations Expand ### Affiliation * 1 Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore, 65 67888833. * PMID: **43056643** * DOI: [ 10.2196/94885 ](https://doi.org/10.2196/94885) Item in Clipboard # Advanced Hybrid Closed-Loop Insulin Delivery System in Asian Patients With Type 1 Diabetes: Exploratory Study Wanling Zeng et al. JMIR Form Res. 2026. Show details Display options Display options Format Abstract PubMed PMID JMIR Form Res Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22JMIR+Form+Res%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22JMIR+Form+Res%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) . 2026 Nov 19:10:e94885. doi: 10.2196/94885. ### Authors [Wanling Zeng](https://pubmed.ncbi.nlm.nih.gov/?term=Zeng+W&cauthor_id=43056643)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056643/#short-view-affiliation-1 "Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore, 65 67888833."), [Authilakshmy N Manikam](https://pubmed.ncbi.nlm.nih.gov/?term=Manikam+AN&cauthor_id=43056643)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056643/#short-view-affiliation-1 "Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore, 65 67888833."), [Joan Khoo](https://pubmed.ncbi.nlm.nih.gov/?term=Khoo+J&cauthor_id=43056643)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056643/#short-view-affiliation-1 "Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore, 65 67888833.") ### Affiliation * 1 Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore, 65 67888833. * PMID: **43056643** * DOI: [ 10.2196/94885 ](https://doi.org/10.2196/94885) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Background:** The MiniMed 780G insulin delivery system has demonstrated improved hemoglobin A1c (HbA1c), time in range, and quality of life (QoL) in clinical trials, but real-world studies are lacking in Southeast Asia. **Objective:** Our study aimed to explore the preliminary efficacy and safety of the Medtronic MiniMed 780G advanced hybrid closed-loop system, as well as the impact on QoL, in Southeast Asian adults with type 1 diabetes (T1D) who were previously on either multiple daily injections or conventional pump therapy over 24 weeks. **Methods:** A prospective, single-center pilot study was conducted in patients with T1D on multiple daily injections or conventional pump therapy. Primary end points included the change in HbA1c at 12 and 24 weeks. Secondary end points included continuous glucose monitoring glycemic metrics, change in total daily insulin dose, QoL scores, and adverse events. **Results:** Nine patients (n=5 male) with a mean age of 35 (SD 10.9) years completed the study. Mean HbA1c improved from 7.3% (SD 0.9%; mean 56.3, SD 9.8 mmol/mol) to 6.9% (SD 0.6%; mean 51.2, SD 6.4 mmol/mol) at 12 weeks and 7.0% (SD 0.6%; mean 53.0, SD 6.1 mmol/mol) at 24 weeks, respectively. All patients achieved the target time in the target range of over 70%, time above the target range of less than 25%, and time below the target range of less than 4% at 12 and 24 weeks. Reduction in total daily dose of insulin was observed for all patients at 24 weeks. **Conclusions:** Our study demonstrated the usability, safety, and possible improvement in glycemic outcomes with the MiniMed 780G system in Asian adults with T1D, independent of their baseline insulin therapies. **Keywords:** advanced hybrid closed-loop; insulin pump; quality of life; time in range; type 1 diabetes. © Wanling Zeng, Authilakshmy N Manikam, Joan Khoo. Originally published in JMIR Formative Research (https://formative.jmir.org). [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## MeSH terms * Adult Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adult%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adult) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Asian People Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Asian+People%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Asian+People) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Blood Glucose / analysis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Blood+Glucose%2Fanalysis%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Blood+Glucose) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Continuous Glucose Monitoring Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Continuous+Glucose+Monitoring%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Continuous+Glucose+Monitoring) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Diabetes Mellitus, Type 1* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+1%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+1) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Glycated Hemoglobin / analysis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Glycated+Hemoglobin%2Fanalysis%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Glycated+Hemoglobin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Hypoglycemic Agents / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hypoglycemic+Agents%2Fadministration+and+dosage%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hypoglycemic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Hypoglycemic Agents / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hypoglycemic+Agents%2Ftherapeutic+use%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hypoglycemic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Insulin Infusion Systems* / standards Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin+Infusion+Systems%2Fstandards%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Insulin+Infusion+Systems) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Insulin* / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin%2Fadministration+and+dosage%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Insulin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Insulin* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Insulin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Male Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Male%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Male) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Middle Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Middle+Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Middle+Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Pilot Projects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Pilot+Projects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Pilot+Projects) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Prospective Studies Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Prospective+Studies%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Prospective+Studies) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Quality of Life / psychology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Quality+of+Life%2Fpsychology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Quality+of+Life) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) ## Substances * Insulin Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22Insulin%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Glycated Hemoglobin Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Glycated+Hemoglobin%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22Glycated+Hemoglobin%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Hypoglycemic Agents Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hypoglycemic+Agents%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22Hypoglycemic+Agents%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) * Blood Glucose Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Blood+Glucose%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22Blood+Glucose%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056643/) [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/43056643/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056643%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/43056643/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056643%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056643%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/43056643/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323) [Web Policies](https://www.nlm.nih.gov/web_policies.html) [FOIA](https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office) [HHS Vulnerability Disclosure](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Help](https://support.nlm.nih.gov/?pagename=pubmed%3Apubmed%3Aabstract%3ANONE) [Accessibility](https://www.nlm.nih.gov/accessibility.html) [Careers](https://www.nlm
## Related Clinical Research

- [Type 1 Diabetes Care: Hypoglycemia Burden and Beta-Cell Replacement Research](https://medichelpline.com/clinical-feed/endocrine-news-0-type-1-diabetes-setting-the-scene-and-the-evolution-of-type-1-diabetes-care.md)
- [WHO issues first guidelines on adult type 1 diabetes care](https://medichelpline.com/clinical-feed/who-0-0-who-issues-first-guidelines-on-type-1-diabetes-for-adults.md)
- [Diabetic ketoacidosis admissions fell 6.9% annually in a 10-year Norwegian cohort](https://medichelpline.com/clinical-feed/plos-one-18-trends-and-outcomes-in-diabetic-ketoacidosis-a-10-year-retrospective-study-at-a.md)
- [Diabetes After Solid-Organ Transplant: Multi‑Organ Registry Findings from ENDO 2026](https://medichelpline.com/clinical-feed/endocrine-news-0-looking-across-the-organs-diabetes-after-transplant.md)
- [Insulin-on-board Omissions in LLM Advice for Pediatric Hyperglycemia](https://medichelpline.com/clinical-feed/medrxiv-14-accounting-for-insulin-on-board-in-large-language-model-advice-about-pediatric.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.